AZ strikes new deals with two Asian companies

Thursday 22 December 2011

AstraZeneca Plc has struck deals with companies operating in China and Japan giving it access to novel compounds in the therapeutic areas of oncology and diabetes. The separate deals involve preclinical and clinical assets.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom